Cardiology (all articles)
POTS and Pregnancy: a review of literature and recommendations for evaluation and treatment
10 Feb, 2023 | 13:37h | UTC
Cohort Study | Adverse pregnancy outcomes and long-term risk of ischemic heart disease in mothers
9 Feb, 2023 | 14:02h | UTCNews Release: Five major adverse pregnancy outcomes associated with long term risks of ischemic heart disease – News Medical/BMJ
Commentary: Complications during pregnancy linked to a higher risk of heart disease, study finds – CNN
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Gestational Hypertension and Future Risk of Cardiovascular Disease
Cohort Study | Middle-age high normal serum sodium as a risk factor for chronic diseases and premature mortality
9 Feb, 2023 | 13:38h | UTCNews Release: Good hydration linked to healthy aging – National Institutes of Health
Retrospective Cohort | Survivors of sepsis are at increased risk of late cardiovascular events
8 Feb, 2023 | 12:46h | UTCNews Release: Sepsis increased risk of heart failure and rehospitalization after hospital discharge – American Heart Association
Commentaries:
Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis – TCTMD
Cardiovascular Hospitalization Increased After Sepsis Hospitalization – HealthDay
Review | Liberation from mechanical ventilation in the cardiac intensive care unit
8 Feb, 2023 | 12:45h | UTCLiberation From Mechanical Ventilation in the Cardiac Intensive Care Unit – JACC: Advances
Review | Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome
8 Feb, 2023 | 12:38h | UTC
Commentary on Twitter
In our latest Comment, Fedorowski & Sutton discuss the role of autonomic dysfunction and postural orthostatic tachycardia syndrome (POTS) in post-acute #COVID19 syndrome: https://t.co/gJ08XxnfQ6 pic.twitter.com/FmC9JwDs4C
— Nature Reviews Cardiology (@NatRevCardiol) February 2, 2023
Crossover RCT | Effects of SGLT2 inhibition on sodium in patients with chronic syndrome of inappropriate antidiuresis
8 Feb, 2023 | 12:34h | UTC
Commentary on Twitter
The syndrome of inappropriate antidiuresis (SIAD) is a major cause of hypotonic hyponatremia. This study shows the SGLT2 inhibitor empagliflozin is a promising new treatment for chronic SIAD-induced hyponatremia, possibly improving neurocognitive function https://t.co/U26RNmVM9j pic.twitter.com/8pH6xqSs7D
— JASN_News (@JASN_News) December 12, 2022
M-A | Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk
8 Feb, 2023 | 12:16h | UTCDual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials – European Heart Journal (link to abstract – $ for full-text)
Commentary on Twitter
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomised trials https://t.co/bIX3fAuOEU @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/WuzOckXpFX
— European Society of Cardiology Journals (@ESC_Journals) December 20, 2022
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts
8 Feb, 2023 | 12:14h | UTCMachine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts – The Lancet (link to abstract – $ for full-text)
News Release: Digital marker for coronary artery disease built by researchers at Mount Sinai
Commentary: Machine learning used to generate a new holistic model for coronary artery disease – News Medical
Commentary from the author on Twitter (thread – click for more)
Christmas came early… my first paper of my postdoc is officially published @TheLancet!! https://t.co/pozEyRKkD0
This was a wild journey with the @DoGenetics lab to build a digital marker for heart disease using AI + electronic health records🫀🤖 Here's why:
1/🧵— Iain S. Forrest, PhD (@IainSForrest) December 21, 2022
Cohort Study | Analysis of factors associated with coronary arterial aneurysm regression in patients with Kawasaki disease
7 Feb, 2023 | 13:56h | UTCRelated:
Intravenous immunoglobulin for the treatment of Kawasaki disease – Cochrane Library
Systematic Review: Corticosteroids for the treatment of Kawasaki disease in children.
Review | Valvular heart disease: shifting the focus to the myocardium
7 Feb, 2023 | 13:37h | UTCValvular heart disease: shifting the focus to the myocardium – European Heart Journal
Commentary on Twitter
Valvular heart disease: shifting the focus to the myocardium https://t.co/u1Nu7nnQvq @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/QFM8BJItRl
— European Society of Cardiology Journals (@ESC_Journals) October 10, 2022
Phase 2 RCT | Baxdrostat for treatment-resistant hypertension
6 Feb, 2023 | 13:38h | UTCPhase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
Aldosterone has long been a pharmacologic target for the treatment of hypertension. However, a new small-molecule drug called baxdrostat inhibits aldosterone synthase in patients with treatment-resistant hypertension. 1/14 pic.twitter.com/F27WE4Wa1d
— NEJM (@NEJM) February 3, 2023
RCT | Personalized accelerated pacing may improve QOL in patients with heart failure with preserved EF
6 Feb, 2023 | 13:35h | UTCEffect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial – JAMA Cardiology (free for a limited period)
News Release: Speeding up heart rate helps heart failure patients with stiff hearts – University of Minnesota Medical School
Commentary on Twitter
In study of patients with HFpEF and pacemakers, moderately accelerated pacing (median pacing rate 75bpm) improved health-related QOL, natriuretic peptide levels, activity levels, and Afib compared w/ standard 60 bpm setting. https://t.co/Ow3W3qD6DM @maggieinfeld @markusmeyermd
— JAMA Cardiology (@JAMACardio) February 1, 2023
The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
6 Feb, 2023 | 13:24h | UTCOriginal Guideline: #ESCCongress | 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Case-control study | Association of anthracycline with heart failure in patients treated for breast cancer or lymphoma, 1985-2010
6 Feb, 2023 | 13:20h | UTCInvited Commentary: Heart Failure in Patients With Cancer Treated With Anthracyclines—Revisiting the Foundation of Cardio-Oncology- JAMA Network Open
Commentary on Twitter
Anthracycline is linked to double the rate of heart failure in patients with cancer vs matched controls, 7.4% at 15 years. https://t.co/SxlJkJ7oLR
— JAMA Network Open (@JAMANetworkOpen) February 3, 2023
M-A | Cardiac resynchronization may improve outcomes in patients with intraventricular conduction delay but not in those with RBBB
6 Feb, 2023 | 13:13h | UTCCardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials – Circulation (free for a limited period)
Commentary: CRT Likely Benefits Broader Group of Patients: Meta-analysis – TCTMD
Commentary on Twitter
#OriginalResearch: In this patient level meta-analysis of RCTs, #CRT was associated with better outcomes in patients with QRS ≥150ms and IVCD or LBBB, but not RBBB @DanFriedmanMD @DrMGold1 @AnneBCurtis @VKutyifa @FudimMarat @F_dalgaard https://t.co/ptW1u9Op1E pic.twitter.com/qBxbiMxz4S
— Circulation (@CircAHA) February 1, 2023
Cohort Study | Predictors of acute coronary occlusion in patients with out-of-hospital cardiac arrest without ST-segment elevation
3 Feb, 2023 | 14:20h | UTCAcute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest – Journal of the American College of Cardiology (link to abstract – $ for full-text)
JACC Podcast: Acute Coronary Occlusion in Patients with Non-ST-segment Elevation Out-of-hospital Cardiac Arrest
Commentary: Coronary Occlusion in Patients With Non-ST Elevation Cardiac Arrest – American College of Cardiology
Related:
Emergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac Arrest: Results of the Randomized, Multicentric EMERGE Trial – JAMA Cardiology (link to abstract – $ for full-text)
M-A | Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure
3 Feb, 2023 | 14:23h | UTC
Global, regional, and national burdens of ischemic heart disease attributable to smoking from 1990 to 2019
3 Feb, 2023 | 14:25h | UTC
Diagnostic accuracy study | Natriuretic peptide testing and heart failure diagnosis in primary care
3 Feb, 2023 | 14:04h | UTC
Transfusion thresholds for acute coronary syndromes — insights from the TRICS‐III trial and meta‐analysis
3 Feb, 2023 | 13:58h | UTC
Cohort Study | Autoimmune diseases and new-onset atrial fibrillation
3 Feb, 2023 | 13:52h | UTCAutoimmune diseases and new-onset atrial fibrillation: a UK Biobank study – EP Europace
SR | Paracetamol for patent ductus arteriosus in preterm or low birth weight infants
3 Feb, 2023 | 13:47h | UTC
Commentary on Twitter
Is paracetamol effective and safe, compared with placebo, no intervention, or another prostaglandin inhibitor, for PDA in preterm or LBWls? Jasani B, @souvik_neo, and Shah PS updated a systematic review in @CochraneLibrary.https://t.co/ZD3tMC6LuH#EBNeoAlerts #NeoEBM pic.twitter.com/gmQc1eem4n
— Evidence-Based Neo (@EBNEO) December 29, 2022
RCT | Ablation vs. anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation
3 Feb, 2023 | 13:40h | UTC
Deconstructing the dogma: meta-analysis of adjunctive gentamicin and rifampin in staphylococcal prosthetic valve endocarditis
2 Feb, 2023 | 15:00h | UTC
Commentary on Twitter
So excited to share an #IDTwitter collaborative article!
Together with @Cortes_Penfield @DrToddLee @syctong @DrEmilyMcD @JGPharmD and Irani Thevarajan, we did a systematic review & meta-analysis on gent & rifampin in Staph prosthetic valve endocarditis!https://t.co/XocwPvut3x
— Jonathan Ryder, MD (@JonathanRyderMD) October 31, 2022